Crescent Biopharma, Inc.

Bank of New York Mellon Corp CBIO

Report date

12/31/2023

Quarter

2023 Q4

Filed

1/29/2024

Shares

24,732

Value ($000)

58

Weight

0.0%

2014 Q1 - 2023 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	1/29/2024	58	0.0%	24,732	12/31/2023
2023 Q3	10/24/2023	37	0.0%	24,875	9/30/2023
2023 Q2	8/3/2023	44	0.0%	25,109	6/30/2023
2023 Q1	5/9/2023	32	0.0%	25,172	3/31/2023
2022 Q4	2/14/2023	79	0.0%	26,168	12/31/2022
2022 Q3	11/14/2022	14	0.0%	26,238	9/30/2022
2022 Q2	8/15/2022	16	0.0%	26,238	6/30/2022
2022 Q1	5/11/2022	30	0.0%	26,299	3/31/2022
2021 Q4	2/11/2022	38	0.0%	26,299	12/31/2021
2021 Q3	11/18/2021	58	0.0%	26,299	9/30/2021
2021 Q2	8/11/2021	62	0.0%	26,664	6/30/2021
2021 Q1	5/13/2021	410	0.0%	136,337	3/31/2021
2020 Q4	2/9/2021	496	0.0%	132,232	12/31/2020
2020 Q3	11/12/2020	397	0.0%	129,219	9/30/2020
2020 Q2	8/12/2020	474	0.0%	126,207	6/30/2020
2020 Q1	5/6/2020	278	0.0%	121,911	3/31/2020
2019 Q4	2/14/2020	598	0.0%	113,032	12/31/2019
2014 Q1	5/14/2014	335	0.0%	20,532	3/31/2014